Divalproex and Cholestyramine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Divalproex (divalproex sodium) and Cholestyramine (cholestyramine). Common drug interactions include blood glucose increased among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Divalproex and Cholestyramine. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Divalproex?

Divalproex has active ingredients of divalproex sodium. It is often used in bipolar disorder. eHealthMe is studying from 14,063 Divalproex users. Check the latest studies of Divalproex.

What is Cholestyramine?

Cholestyramine has active ingredients of cholestyramine. It is often used in diarrhea. eHealthMe is studying from 9,893 Cholestyramine users. Check the latest studies of Cholestyramine.

On Jul, 15, 2026

33 people who take Divalproex and Cholestyramine together, and have interactions are studied.

Divalproex and Cholestyramine drug interactions.

What are the common drug interactions of Divalproex and Cholestyramine, by gender? *:

female:

Blood glucose increased
Chest pain
Confusional state
Depression
Dry eye (lack of adequate tears)
Gastrointestinal stoma complication (complication of an opening surgically made in digestive tract)
Peripheral swelling
Pneumonia
Renal impairment (severely reduced kidney function)
Sepsis (a severe blood infection that can lead to organ failure and death)

male:

Chronic kidney disease
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Death
Dysstasia (difficulty in standing)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Urinary tract infection
Abdominal discomfort
Abnormal behaviour
Asthenia (weakness)
Ataxia (loss of full control of bodily movements)

What are the common drug interactions of Divalproex and Cholestyramine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chronic kidney disease
Gait disturbance
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Dysstasia (difficulty in standing)
Emotional distress
Pain
Renal failure (kidney dysfunction)

50-59:

Anxiety
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Chronic kidney disease
Emotional distress
Glomerulonephritis membranous (nephritis with inflammation of the capillary loops in the renal glomeruli)
Pain
Tooth loss
Chest pain
Confusional state
Depression

60+:

Death
Gastrointestinal stoma complication (complication of an opening surgically made in digestive tract)
Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)
Depressed mood
Gait disturbance
Glycosylated haemoglobin increased
Hospitalisation
Inappropriate affect
Incoherent (talking in a confused and unclear way)
Intervertebral disc degeneration (spinal disc degeneration)

What are the existing conditions these people have? *

Hiv Infection: 5 people, 15.15%
Multiple Myeloma (cancer of the plasma cells): 4 people, 12.12%
Hyperkalemia (damage to or disease of the kidney): 3 people, 9.09%
Gastrointestinal Stoma Complication (complication of an opening surgically made in digestive tract): 3 people, 9.09%
Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Divalproex and Cholestyramine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously